<ѻý>Large-Scale Intensive BP Intervention Proves Sustainable for CVD Preventionѻý> Community-based program reduced events regardless of age, diabetes Jun 18, 2024
<ѻý>Train Eyes So Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Strokeѻý> Also in TTHealthWatch: cancers subsequent to CAR-T therapy Jun 15, 2024 podcast
<ѻý>Postpartum Readmissions Up With High Blood Pressures Lingering From Pregnancyѻý> Concerns about BP thresholds for antihypertensive medication initiation Jun 12, 2024
<ѻý>Increased Heart Risks With Newer Prostate Cancer Drugs, Meta-Analysis Showsѻý> Adding ARSIs to ADT for advanced disease doubled the risk of high-grade CV events, death Jun 06, 2024
<ѻý>Better Cognitive Outcomes Tied to Vigorous Exercise in Hypertensive Adultsѻý> SPRINT MIND analysis looks at 7,600 older adults at high risk of cognitive decline Jun 06, 2024
<ѻý>Hypertension After Kidney Donation; Statins in Old and Very Old Peopleѻý> Also in TTHealthWatch: fluoride's effect on pregnancy outcomes Jun 01, 2024 podcast
<ѻý>Draw Between Two Diuretics for Renal Prevention in Hypertensionѻý> But researcher questions if patients were underdosed May 16, 2024
<ѻý>Novel Biannual Antihypertensive Shows Potential for Combination Therapyѻý> Drug might be most effective with a diuretic, according to suggestive data from a phase II trial Apr 09, 2024
<ѻý>Oral Appliance for Sleep Apnea Noninferior to CPAP for Reducing Arterial BPѻý> For patients with hypertension, oral device may be an option for those who cannot tolerate CPAP Apr 09, 2024
<ѻý>Primary Care Strategy Fails to Reduce Kidney-Dysfunction Triad Hospitalizationsѻý> Secondary outcomes also showed no significant differences Apr 03, 2024
<ѻý>Sotatercept's FDA Approval a New Chapter for Pulmonary Arterial Hypertensionѻý> Biologic should arrive on pharmacy shelves before May Mar 27, 2024
<ѻý>Fixed-Dose Macitentan/Tadalafil Combo Gets FDA Approval for PAHѻý> Opsynvi puts two drugs commonly prescribed for pulmonary arterial hypertension into one tablet Mar 25, 2024
<ѻý>Novel Oral Antihypertensive Gets FDA's Blessingѻý> Aprocitentan becomes the first endothelin receptor antagonist for BP lowering Mar 20, 2024
<ѻý>EHR Alerts Trigger Primary Care Clinics to Improve Hypertension Care in CKDѻý> Greater reduction in systolic BP over usual care in randomized trial Mar 15, 2024
<ѻý>Deaths Due to Alcohol Use; Steps for the Sedentaryѻý> Also in TTHealthWatch: microplastics in arteries, and worldwide obesity and diabetes risk Mar 09, 2024 podcast
<ѻý>Interventions Can Reduce CVD Risk Factors in HIV Patients, Studies Showѻý> Lowering blood pressure, cholesterol prove feasible in randomized trials Mar 07, 2024
<ѻý>Primordial Prevention Can Protect Black Women's Cardiovascular Healthѻý> Let's block the risk factors before they start Feb 19, 2024
<ѻý>Hypertension, Diabetes in Pregnancy Affects Offspring's Heart Health in Adolescenceѻý> Hypertensive disorders of pregnancy and gestational diabetes are both on the rise Feb 16, 2024
<ѻý>RNA Silencer Zilebesiran: Infrequent Injections Bring Down BPѻý> Sustained BP reductions seen in early trial whether patients got one or two doses in 6 months Feb 16, 2024
<ѻý>Tirzepatide's Association With BP Reduction Reinforced With ABPM Dataѻý> Combination GLP-1/GIP receptor agonist is currently approved for T2D and weight loss Feb 05, 2024
<ѻý>Health Record Trigger Boosted Screening for Primary Aldosteronismѻý> Best-practice advisory tested in adults with hypertension Jan 08, 2024
<ѻý>Is Your Patient Married? Check Their Spouse's Blood Pressure, Tooѻý> Couple-centered strategies can help manage hypertension Dec 18, 2023
<ѻý>High-Altitude Mountain Trips Can Be Tolerated Despite Pulmonary Hypertensionѻý> Effects of high elevation tested in an experiment in the Swiss Alps Dec 12, 2023
<ѻý>Doc Set Home on Fire? High Blood Pressure in Couples; WHO: Raise Alcohol, Soda Taxesѻý> Health news and commentary from around the Web gathered by ѻý staff Dec 06, 2023
<ѻý>High Blood Pressure in Babies Linked to Adult Atherosclerosisѻý> Is BP screening starting before age 3 years warranted? Dec 04, 2023
<ѻý>Coronary Heart Disease by Age 45 Linked With Subsequent Dementiaѻý> All-cause dementia, Alzheimer's disease, and vascular dementia risks elevated Nov 29, 2023
<ѻý>Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Eventsѻý> Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
<ѻý>Lowering the Target for Blood Pressure Is Best, Study Affirmsѻý> Huge trial from China reinforces the message from SPRINT for higher-risk hypertensive patients Nov 13, 2023
<ѻý>Intensive Blood Pressure Lowering Cuts Dementia Riskѻý> Benefit finally proven in clinical trial Nov 12, 2023
<ѻý>Antihypertensives Do Not Detract From the BP Reduction of a Low-Sodium Dietѻý> Dietary change produces clinically relevant BP changes within a week Nov 12, 2023
<ѻý>FDA Approves First Renal Denervation System for Hypertensionѻý> Catheter-based technology will finally enter the market with ultrasound-based device Nov 08, 2023
<ѻý>Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplantѻý> Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
<ѻý>Heart Injuries Suggest Reconsideration of Holding BP Meds for Surgeryѻý> Pause on ACE inhibitors, ARBs yields more acute hypertension with no prevention of hypotension Nov 06, 2023
<ѻý>Pharmacist Prescribing for BP Control Makes Economic Senseѻý> Clinical benefits of pharmacist-prescribed antihypertensives known for years Nov 03, 2023
<ѻý>'Surprising' Contribution of Pulmonary Hypertension to ARDS Outcomesѻý> Coexisting conditions spell markedly poor clinical course Oct 12, 2023
<ѻý>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Saysѻý> Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<ѻý>Adherence Matters for CVD Secondary Prevention in CPAP Usersѻý> Questionable benefit may hinge on number of hours used Oct 05, 2023
<ѻý>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enoughѻý> Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<ѻý>Lorundrostat Stands a Chance Against Obesity-Related Hypertensionѻý> Selective aldosterone synthase inhibitor proceeds to phase III study after Target-HTN's success Sep 10, 2023
<ѻý>Optimal BP After Stroke; Psilocybin for Depressionѻý> Also in TTHealthWatch: culprit vessel or complete revascularization? Sep 09, 2023 podcast